Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H27N3O |
| Molecular Weight | 313.4372 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)N2CCN(C)CC2)C3=C1C=CC=C3
InChI
InChIKey=IUEFFEOHJKCBPF-UHFFFAOYSA-N
InChI=1S/C19H27N3O/c1-3-4-7-10-22-15-17(16-8-5-6-9-18(16)22)19(23)21-13-11-20(2)12-14-21/h5-6,8-9,15H,3-4,7,10-14H2,1-2H3
| Molecular Formula | C19H27N3O |
| Molecular Weight | 313.4372 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2096981 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29367864 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Postmortem distribution of mepirapim and acetyl fentanyl in biological fluid and solid tissue specimens measured by the standard addition method. | 2019 |
|
| Identification and quantification of mepirapim and acetyl fentanyl in authentic human whole blood and urine samples by GC-MS/MS and LC-MS/MS. | 2018 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:10:34 GMT 2025
by
admin
on
Mon Mar 31 23:10:34 GMT 2025
|
| Record UNII |
W6OZW1T05K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MEPIRAPIM
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
W6OZW1T05K
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
PRIMARY | |||
|
101896603
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
PRIMARY | |||
|
2365542-29-4
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
PRIMARY | |||
|
MEPIRAPIM
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
PRIMARY | MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group(1) and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. | ||
|
MEPIRAPIM
Created by
admin on Mon Mar 31 23:10:34 GMT 2025 , Edited by admin on Mon Mar 31 23:10:34 GMT 2025
|
PRIMARY | MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group(1) and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->WEAK AGONIST |
Ki
|
||
|
|
TARGET->WEAK AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |